Viking Therapeutics, Inc. (VKTX) awards director new options and RSUs
Rhea-AI Filing Summary
Dorothy Elizabeth Kelly-Gemmell, a director of Viking Therapeutics, Inc., received equity awards on August 1, 2026. She was granted a restricted stock unit award covering 6,333 shares of common stock, vesting in three equal annual installments, and stock options for 40,800 shares at an exercise price of $31.74 per share, also vesting one-third on each anniversary and expiring on August 1, 2036.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 6,333 shares
Net Buy
2 txns
Insider
Kelly-Gemmell Dorothy Elizabeth
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) F2 | 40,800 | $0.00 | $0.00 |
| Grant/Award | Common Stock, par value $0.00001 per share F1 | 6,333 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (Right to Buy) — 40,800 shares (Direct);
Common Stock, par value $0.00001 per share — 6,333 shares (Direct)
Footnotes (2)
- F1. Represents a restricted stock unit award ("RSU") of common stock under the Issuer's 2024 Equity Incentive Plan. One-third of the shares subject to the RSU shall vest on each one year anniversary of the grant date of the award.
- F2. One-third of the shares subject to the option will vest on each anniversary of the grant date.
Key Figures
RSU shares granted: 6,333 shares
Option shares granted: 40,800 shares
Option exercise price: $31.74 per share
+3 more
6 metrics
RSU shares granted
6,333 shares
Restricted stock units of common stock granted on 2026-08-01
Option shares granted
40,800 shares
Stock options granted on 2026-08-01
Option exercise price
$31.74 per share
Exercise price for 40,800 stock options
Option expiration date
2036-08-01
Expiration date of the reported stock options
RSU vesting schedule
One-third per year
One-third of RSU shares vest on each one-year anniversary
Option vesting schedule
One-third per year
One-third of option shares vest on each anniversary of grant date
Key Terms
restricted stock unit, Equity Incentive Plan, Stock Option (Right to Buy)
3 terms
restricted stock unit financial
"Represents a restricted stock unit award RSU of common stock"
A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.
Equity Incentive Plan financial
"under the Issuer's 2024 Equity Incentive Plan"
An equity incentive plan is a program that gives employees, executives or directors the right to receive company stock or options to buy stock as part of their pay. Think of it as offering slices of future company profit to motivate people to boost long‑term performance; for investors it matters because it can align employee goals with shareholder value but also increases the number of shares outstanding, which can dilute existing ownership.
Stock Option (Right to Buy) financial
"security_title: Stock Option (Right to Buy)"
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What equity awards did Viking Therapeutics (VKTX) director Dorothy Elizabeth Kelly-Gemmell receive on August 1, 2026?
Dorothy Elizabeth Kelly-Gemmell received 6,333 RSUs and stock options for 40,800 shares of Viking Therapeutics common stock. Both awards vest in three equal annual installments starting on the first anniversary of the grant date.
How many RSUs did Viking Therapeutics (VKTX) grant and how do they vest?
Viking Therapeutics granted 6,333 restricted stock units of common stock to director Dorothy Elizabeth Kelly-Gemmell. According to the award terms, one-third of the RSU shares vests on each one-year anniversary of the August 1, 2026 grant date, over three years.
What are the key terms of the VKTX stock options granted to Dorothy Elizabeth Kelly-Gemmell?
She received stock options for 40,800 shares of Viking Therapeutics common stock with an exercise price of $31.74 per share. One-third vests on each anniversary of the August 1, 2026 grant date, and the options expire on August 1, 2036.
When do the Viking Therapeutics (VKTX) RSUs and options begin to vest for Dorothy Elizabeth Kelly-Gemmell?
Both the 6,333 RSUs and the 40,800 stock options begin vesting on the first anniversary of the August 1, 2026 grant date. One-third of the shares under each award vests on each subsequent one-year anniversary.
Are Dorothy Elizabeth Kelly-Gemmell’s VKTX equity awards reported as part of a Rule 10b5-1 trading plan?
The filing’s Rule 10b5-1 checkbox is not marked as affirmed, and the footnotes describe only vesting terms. The disclosure does not state that these particular RSU and option grants were made under a Rule 10b5-1 trading plan.